课题基金 / 基金详情

PFI-TT: Cold plasma technology to enable a future cancer treatment device to reduce surgical margins

PFI-TT: Cold plasma technology to enable a future cancer treatment device to reduce surgical margins
PFI-TT:冷等离子体技术使未来的癌症治疗设备能够减少手术切缘
批准号:
1919019
负责人:
Michael Keidar
金额:
$25.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2021-07-31

项目摘要

项目成果

Michael Keidar的其他基金

相似基金

相关文献

中文摘要
翻译
这一创新-技术转化伙伴关系(PFI-TT)项目的广泛影响/商业潜力满足了治疗癌症手术中确定的手术切缘或边缘的重要需求。拟议的活动将是开发被称为“冷大气等离子体”的创新技术,以治疗肿瘤边缘和其他癌症手术涉及的领域。这项技术将更接近市场准备,可能会影响到国民经济的几个部门,包括医疗设备和科学设备。此外,包括研究生和博士后科学家在内的相关研究人员的职业生涯将受益于扩大他们在新兴血浆医学领域的网络并增强他们的领导技能。特别是,其中一名博士后将被提升为该项目的技术商业化专家。此外,研究伙伴之间的合作确保了拟议项目的成功实施,这些伙伴与世界领先的等离子材料科学和生物医学研究专家组成了一个高资质的联盟。拟议项目融合了多用途等离子体源的新工程努力和用于癌症治疗的生物材料表面处理方面的杰出进展。拟议的项目具有跨学科性质,具有基础性和技术性意义。其基本意义在于探索冷大气等离子体的医疗作用,特别是等离子体与肿瘤和手术切缘的相互作用。为此,将制造一种灵活的、可变形的、可适应任何表面形貌的等离子体设备。此外,还将使用广泛的诊断仪器,以及用于体外测试的化学和生物传感器,这基本上构成了该项目的技术意义。等离子体状态将主要由光学等离子体诊断来表征。通过电子显微镜对表面形貌的监测,以及对化学成分和生物特性的评估,将评估处理后表面的最终状态。其主要目标是以生物医学应用为目标对非平面和微细材料进行均匀处理,特别是以癌症治疗应用为重点的有机组织的等离子体处理。总而言之,该项目将开创通过扩展变形等离子体源治疗复杂几何表面的先河,重点放在肿瘤和手术边缘的治疗上。该奖项反映了NSF的法定使命,并通过使用基金会的智力优势和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
The broader impact/commercial potential of this Partnerships for Innovation - Technology Translation (PFI-TT) project addresses the important need of treating the surgical margins, or edges, identified in cancer operations. The proposed activity will be to develop innovative technology known as "cold atmospheric plasma" to treat the edges of tumors and other areas involved in cancer surgeries. The technology will be advanced closer to market readiness, potentially impacting several sectors of the national economy, including medical equipment and scientific devices. Also, the careers of the involved researchers, which include graduate students and postdoctoral scientists, will be benefited by increasing their networks in the emerging field of plasma medicine and enhancing their leadership skills. In particular, one of the postdocs will be promoted as technology commercialization expert in this project. In addition, the successful implementation of the proposed project is ensured by the cooperation among the research partners, which constitute a highly qualified consortium with world-leading experts in plasma-material science and biomedical research.The proposed project merges novel engineering efforts towards a versatile plasma source and outstanding advances in surface treatment of biomaterials aiming to cancer therapy. The proposed project has an interdisciplinary nature and it has both fundamental and technological significances. The fundamental significance resides in exploring medical action of cold atmospheric plasmas, in particular plasma interaction with tumor and surgical margins. For this, a flexible, morphing plasma device adaptable to any surface topography will be fabricated. Also, a wide spectrum of diagnostic instrumentations, and chemical and biological sensors for in vitro tests will be employed, which basically constitutes the technological significance of the project. Plasma state will be characterized basically by optical plasma diagnostics. The monitoring of topographies by electron microscopy, as well as evaluation of the chemical composition and biological properties, will assess the end state of the treated surfaces. The main goal consists in uniform treatment of non-planar and delicate materials with the aim of biomedical applications, especially plasma treatment of organic tissues with focus on cancer therapy applications. In summary, this project will pioneer the treatment of complex geometry surfaces by means of an extended morphing plasma source, with emphasis on treatment of tumors and of surgical margins.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
RAPID: Cold Adaptive Atmospheric Plasma Decontamination of COVID-19
  • 批准号:
    2027876
  • 项目类别:
    Standard Grant
  • 资助金额:
    $20.0万
  • 财政年份:
    2020
  • 负责人:
    Michael Keidar
  • 依托单位:
IUCRC Phase I GWU: Center for High Pressure Plasma Energy, Agriculture, and Biomedical Technologies (PEAB)
  • 批准号:
    1747760
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $75.0万
  • 财政年份:
    2018
  • 负责人:
    Michael Keidar
  • 依托单位:
I-Corps: Cold Plasma Cancer Therapy
  • 批准号:
    1637906
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2016
  • 负责人:
    Michael Keidar
  • 依托单位:
Collaborative Research: Exploring Cold Atmospheric Plasma Physics
  • 批准号:
    1465061
  • 项目类别:
    Standard Grant
  • 资助金额:
    $22.2万
  • 财政年份:
    2015
  • 负责人:
    Michael Keidar
  • 依托单位:
国内基金
海外基金
低磷胁迫下TT8-PHRs-DELLAs模块调控苜蓿叶片磷分配的分子机制
  • 批准号:
    32573581
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2025
  • 负责人:
    刘金隆
  • 依托单位:
叶绿体蛋白 TT3.2 调控水稻耐热性的分子机制研究
  • 批准号:
    24ZR1431200
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    郭亮星
  • 依托单位:
TT1响应乙烯调控水稻耐高温的分子机理
晶粒和晶界划伤变形对核用690TT合金应力腐蚀行为影响机制研究
  • 批准号:
    52403407
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2024
  • 负责人:
    吴斌
  • 依托单位: